Type II Diabetes Mellitus Management in Hemodialysis Patients
Type 2 Diabetes Mellitus remains to be the leading cause of end-stage kidney disease (ESKD) globally, with its prevalence continuing to rise. This e-Learning course explores the unique challenges of managing Type 2 Diabetes in this population, including altered insulin metabolism, the limitations of HbA1c as a glycemic marker, and the complexities of treatment planning. It also highlights the critical role of diabetes education and care coordination in improving outcomes for patients with ESKD, particularly those undergoing hemodialysis.
The Kidneys in Health and Disease
This course will review renal anatomy and nephron structure, principles of renal physiology, Acute Kidney Injury (AKI) prevalence and classification, Chronic Kidney Disease (CKD) prevalence and classification. #Spanish
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Fluids, Electrolytes, Acids and Bases
This course provides a comprehensive overview on major components of body fluid, mechanisms of homeostasis and their impact on fluid movement. It will review acid/base chemistry and roles of electrolytes in normal body functions. It will also cover how these components are regulated by the kidneys, the possible causes, symptoms and treatment strategies of imbalances in patients with kidney disease.
A Practical Approach to Sodium Management in Dialysis Patients
This course will review sodium balance and toxicity in dialysis patients, discuss the role of sodium (NA) according to the new understanding of physiology, explain sodium-water imbalances in dialysis patients, describe dietary approach and sodium management in Hemodialysis (HD) and peritoneal dialysis (PD) patients. #Spanish
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Understanding Hyperphosphatemia and Mineral Bone Disorder
This course discusses the pathophysiology of Mineral Bone Disorder in chronic kidney disease (CKD) and reviews the roles of the major players in mineral bone homeostasis. The course also provides an introduction to the management and treatment approaches for this disorder. #Spanish
Learn about the 2017 Updates of the KDOQI Mineral and Bone Disorder Guidelines and stay up-to-date with topics related to MBD diagnosis, recommended phosphorus intake, goal phosphorus levels, goal PTH levels, and MBD in transplant patients. The key differences between the 2017 and 2009 guideline recommendations are highlighted in the short presentation. Full guideline document can be accessed at the end of the presentation or by clicking on the references icon. Click Here to start presentation.
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Fluid Management in Kidney Disease
This course will describe fluid compartments of the body and the role of the kidneys in fluid management, the consequences of fluid overload in kidney disease, guideline recommendations on fluid management approaches and the principles and applications of tools for measuring and evaluating fluid overload in patients with kidney disease. #Spanish
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Basics of Hypercholesterolemia
This course is designed to provide an introductory overview of hypercholesterolemia and various management strategies for this condition. Several fundamental concepts will be addressed, including the hereditary principles of hypercholesterolemia and the relationship between low-density lipoprotein, lipoprotein(a), and atherosclerosis. Additionally, this course will discuss options for appropriate management of hypercholesterolemia and treatment targets. The role of lipoprotein apheresis will be reviewed, including the definition, indications, and effects of therapy on clinical outcomes in this patient population.
Anemia Management in Kidney Disease
This course discusses the clinical manifestations, diagnostic criteria, etiologies and guideline recommendations on the management of anemia in Chronic Kidney Disease (CKD). It provides an overview on iron deficiency anemia, Erythropoietin Stimulating Agents (ESAs) recommendations, the use of IV vs. oral iron agents and Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs).#Spanish
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Managing Suboptimal Responsiveness to Anemia Treatment for Patients with CKD
New Updates!
This course will provide an overview of key principles associated with the management of anemia in CKD, including factors that may contribute to suboptimal response to anemia treatment. It will also address evidenced-based approaches for patients who do not respond adequately to anemia treatment through series of clinical vignettes.
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Identifying and Overcoming Barriers to Transplantation
This roundtable webinar elearning course will feature a discussion of how to identify and overcome barriers in access to transplantation. In this program, Dr. Elisa Gordon and Dr. Vineeta Kumar will highlight insights from the Northwestern Hispanic Kidney Transplant Program and the UAB Living Donor Navigator Program.
Diabetic Kidney Disease and Use of Sodium Glucose Transporter 2 (SGLT2) Inhibitors
In this course, we will describe the role of the kidneys and sodium glucose transporters (SGLTs) in glucose homeostasis. We will review diagnosis, prevalence, and current treatment options for diabetes and diabetic kidney disease (DKD) and explain the mechanism of action of SGLT2 inhibitors. We will also highlight the importance of early prescribing of SGLT2 inhibitors in CKD and DKD.
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Significance of Serum Albumin as a Clinical Indicator in CKD and ESRD
This course provides a comprehensive overview on the physiology and functional importance of serum albumin, discusses the pathophysiology and methods of evaluation of hypoalbuminemia in CKD and ESRD. It reviews albumin loss associated with different dialysis modalities and the effect of hypoalbuminemia on clinical outcomes.
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
Pharmacological Intervention and Outcomes in Hyperphosphatemia and Mineral Bone Disorder
This course will provide an overview on the characteristics of different phosphate binders for treatment of hyperphosphatemia in dialysis patients. It will describe the general mode of action and administration of phosphate binders, discuss effects of phosphate binders and explain how vitamin D and calcimimetics can be used in the treatment of Secondary Hyperparathyroidism (SHPT), and different barriers to CKD-MBD management. #Spanish
If you have purchased CME credit(s) for this course, please click HERE to view the Learner Notification.
